Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp.

4.32
-0.2300-5.05%
Volume:194.35K
Turnover:824.12K
Market Cap:31.32M
PE:-0.22
High:4.53
Open:4.48
Low:4.11
Close:4.55
52wk High:98.20
52wk Low:3.60
Shares:7.25M
Float Shares:6.48M
Volume Ratio:0.69
T/O Rate:3.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19.9792
EPS(LYR):-62.1862
ROE:-179.21%
ROA:-89.44%
PB:1.01
PE(LYR):-0.07

Loading ...

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

GlobeNewswire
·
Dec 18, 2025

BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout

GlobeNewswire
·
Dec 09, 2025

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

GlobeNewswire
·
Dec 02, 2025

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

GlobeNewswire
·
Nov 25, 2025

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

GlobeNewswire
·
Nov 20, 2025

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

GlobeNewswire
·
Nov 18, 2025

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

GlobeNewswire
·
Nov 07, 2025

BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models

GlobeNewswire
·
Nov 04, 2025

BriaCell’s Promising Breast Cancer Study: A Potential Game Changer?

TIPRANKS
·
Oct 28, 2025

BriaCell says DSMB recommends continuation of Phase 3 Bria-IMT study

TIPRANKS
·
Oct 22, 2025

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

GlobeNewswire
·
Oct 21, 2025

BriaCell announces collaboration with MSK Accelerator Cohort program

TIPRANKS
·
Oct 21, 2025

BriaCell presents Phase 3 clinical biomarker data at ESMO 2025

TIPRANKS
·
Oct 20, 2025

Promising Phase 3 Results for BriaCell’s Bria-IMT in Metastatic Breast Cancer

TIPRANKS
·
Oct 14, 2025

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

GlobeNewswire
·
Oct 13, 2025

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

GlobeNewswire
·
Oct 03, 2025